Literature DB >> 21704388

Balancing act: deubiquitinating enzymes in the nervous system.

Sokol V Todi1, Henry L Paulson.   

Abstract

Many pathways important to the nervous system are regulated by the post-translational conjugation of ubiquitin to target proteins. The reversal of ubiquitination, or deubiquitination, is equally critical to neuronal function. By countering protein ubiquitination, deubiquitinating enzymes (DUBs) help control neuronal fate determination, axonal pathfinding and synaptic communication and plasticity. The significance of DUBs to the nervous system is underscored by links to various neurological diseases. Owing to cell type or substrate specificity, certain DUBs might also represent therapeutic targets for neurodegeneration. Here, we review recent findings that have shaped our current understanding of emerging functions for DUBs in the nervous system.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704388      PMCID: PMC3193880          DOI: 10.1016/j.tins.2011.05.004

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  104 in total

1.  Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.

Authors:  Yuxin Mao; Francesca Senic-Matuglia; Pier Paolo Di Fiore; Simona Polo; Michael E Hodsdon; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

2.  Loss of neurons in the hippocampus and cerebral cortex of AMSH-deficient mice.

Authors:  N Ishii; Y Owada; M Yamada; S Miura; K Murata; H Asao; H Kondo; K Sugamura
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  Persistent activation of cAMP-dependent protein kinase by regulated proteolysis suggests a neuron-specific function of the ubiquitin system in Aplysia.

Authors:  D G Chain; A N Hegde; N Yamamoto; B Liu-Marsh; J H Schwartz
Journal:  J Neurosci       Date:  1995-11       Impact factor: 6.167

4.  Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice.

Authors:  Christopher Anderson; Stephen Crimmins; Julie A Wilson; Greg A Korbel; Hidde L Ploegh; Scott M Wilson
Journal:  J Neurochem       Date:  2005-09-29       Impact factor: 5.372

5.  The Drosophila epsin 1 is required for ubiquitin-dependent synaptic growth and function but not for synaptic vesicle recycling.

Authors:  Hong Bao; Noreen E Reist; Bing Zhang
Journal:  Traffic       Date:  2008-09-15       Impact factor: 6.215

6.  Activity and cellular functions of the deubiquitinating enzyme and polyglutamine disease protein ataxin-3 are regulated by ubiquitination at lysine 117.

Authors:  Sokol V Todi; K Matthew Scaglione; Jessica R Blount; Venkatesha Basrur; Kevin P Conlon; Annalisa Pastore; Kojo Elenitoba-Johnson; Henry L Paulson
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

7.  The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition.

Authors:  Giuseppe Nicastro; Rajesh P Menon; Laura Masino; Philip P Knowles; Neil Q McDonald; Annalisa Pastore
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-14       Impact factor: 11.205

8.  Enhancement of proteasome activity by a small-molecule inhibitor of USP14.

Authors:  Byung-Hoon Lee; Min Jae Lee; Soyeon Park; Dong-Chan Oh; Suzanne Elsasser; Ping-Chung Chen; Carlos Gartner; Nevena Dimova; John Hanna; Steven P Gygi; Scott M Wilson; Randall W King; Daniel Finley
Journal:  Nature       Date:  2010-09-09       Impact factor: 49.962

9.  Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3.

Authors:  Qiuyan Wang; Lianyun Li; Yihong Ye
Journal:  J Cell Biol       Date:  2006-09-25       Impact factor: 10.539

10.  The ataxia (axJ) mutation causes abnormal GABAA receptor turnover in mice.

Authors:  Corinna Lappe-Siefke; Sven Loebrich; Wulf Hevers; Oliver B Waidmann; Michaela Schweizer; Susanne Fehr; Jean-Marc Fritschy; Ivan Dikic; Jens Eilers; Scott M Wilson; Matthias Kneussel
Journal:  PLoS Genet       Date:  2009-09-04       Impact factor: 5.917

View more
  69 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  The de-ubiquitinating enzyme ataxin-3 does not modulate disease progression in a knock-in mouse model of Huntington disease.

Authors:  Li Zeng; Sara J Tallaksen-Greene; Bo Wang; Roger L Albin; Henry L Paulson
Journal:  J Huntingtons Dis       Date:  2013

3.  USP5 Is Dispensable for Monoubiquitin Maintenance in Drosophila.

Authors:  Gorica Ristic; Wei-Ling Tsou; Ermal Guzi; Adam J Kanack; Kenneth Matthew Scaglione; Sokol V Todi
Journal:  J Biol Chem       Date:  2016-02-25       Impact factor: 5.157

4.  Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.

Authors:  Kyoung-in Cho; Hemangi Patil; Eugene Senda; Jessica Wang; Haiqing Yi; Sunny Qiu; Dosuk Yoon; Minzhong Yu; Andrew Orry; Neal S Peachey; Paulo A Ferreira
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

5.  The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster.

Authors:  Wei-Ling Tsou; Michelle Ouyang; Ryan R Hosking; Joanna R Sutton; Jessica R Blount; Aaron A Burr; Sokol V Todi
Journal:  Neurobiol Dis       Date:  2015-05-22       Impact factor: 5.996

6.  Synaptic strength is bidirectionally controlled by opposing activity-dependent regulation of Nedd4-1 and USP8.

Authors:  Samantha L Scudder; Marisa S Goo; Anna E Cartier; Alice Molteni; Lindsay A Schwarz; Rebecca Wright; Gentry N Patrick
Journal:  J Neurosci       Date:  2014-12-10       Impact factor: 6.167

7.  Backbone 1H, 13C, and 15N resonance assignments of deubiquitinase A in non-phosphorylated and phosphorylated forms.

Authors:  Ashish Kabra; Catherine A Benson; Ying Li
Journal:  Biomol NMR Assign       Date:  2018-09-19       Impact factor: 0.746

8.  A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy.

Authors:  C Zhao; X Chen; D Zang; X Lan; S Liao; C Yang; P Zhang; J Wu; X Li; N Liu; Y Liao; H Huang; X Shi; L Jiang; X Liu; Z He; Q P Dou; X Wang; J Liu
Journal:  Oncogene       Date:  2016-04-18       Impact factor: 9.867

Review 9.  Hes1: the maestro in neurogenesis.

Authors:  Sivadasan Bindu Dhanesh; Chandramohan Subashini; Jackson James
Journal:  Cell Mol Life Sci       Date:  2016-05-27       Impact factor: 9.261

10.  The ESCRT-deubiquitinating enzyme USP8 in the cervical spinal cord of wild-type and Vps54-recessive (wobbler) mutant mice.

Authors:  Chiara Paiardi; Maria Enrica Pasini; Alida Amadeo; Mariarosa Gioria; Giovanna Berruti
Journal:  Histochem Cell Biol       Date:  2013-04-25       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.